(Q72298072)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Phase I/II trial of dipyridamole, 5-fluorouracil, leukovorin, and mitoxantrone in metastatic breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

main subject

phase I clinical trial

1 reference

inferred from title

metastatic breast cancer

1 reference

1 reference

G T Budd

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

P Herzog

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

R M Bukowski

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 January 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

25 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

283-287

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00873042

25 October 2019

exact match

0 references

cites work

Refractory metastatic breast cancer: salvage therapy with fluorouracil and high-dose continuous infusion leucovorin calcium

1 reference

12 December 2020

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Potentiation of cytotoxicity of mitoxantrone toward CHO-K1 cells in vitro by dipyridamole

1 reference

12 December 2020

Mitoxantrone, 5-fu, and leucovorin in breast cancer

1 reference

12 December 2020

Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer

1 reference

12 December 2020

Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Dipyridamole enhancement of etoposide sensitivity

1 reference

12 December 2020

Potentiation of methotrexate toxicity by dipyridamole.

1 reference

12 December 2020

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole

1 reference

12 December 2020

Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00873042

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7775128%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference